Author:
Fink F. M.,Gadner H.,Grümayer E. R.,Kardos G.,Revesz T.,Urban Ch.,Mutz I.,Ausserer B.,Schuler D.
Publisher
Springer Berlin Heidelberg
Reference11 articles.
1. Creutzig U, Ritter J, Budde M, Riehm H, Henze G, Lampert F, Gerein V, Müller-Weihrich S, Niethammer D, Spaar HJ, Schellong G (1986) Aktuelle Ergebnisse der kooperativen AML-Therapiestudien bei Kindern: BFM-78 und -83. Klin Pädiatr 198: 183–190
2. Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E III (1980) Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 303 (9): 473–478
3. Gale RP, Foon KA (1988) Daunorubicin or doxorubicin in acute myelogenous leukemia? Leukemia 2 (4): 209–210
4. Pedersen-Bjergaard J, Bricker H, Ellegaard J, Drivsholm A, Freund L, Jensen KB, Jensen MK, Nissen N (1984) Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. Cancer Treat Rep 68: 1233–1238
5. Rowe JM, Chang AYC, Bennett JM (1988) Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia. Blood 71 (4): 992–996
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献